Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasm
QIAGEN and OncXerna enter into a global master agreement to advance the development of the Xerna TME panel as a potential Next Generation Sequencing (NGS) companion diagnostic for OncXerna’s Navicixizumab
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
Hair care & quick commerce shine
The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
On his visit to NIPER Mohali, union health minister vreviews biopharma research initiatives and calls for stronger industry collaboration and commercialization focus
In his new role, Gregory will drive partnerships for the company’s large-scale molecule biologics business across Europe
While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
Subscribe To Our Newsletter & Stay Updated
